A decade ago, physicians who treat epilepsy got what seemed like a piece of good news: Eight companies had received federal approval to sell a generic version of an injectable lifesaving drug.
"The Generic Drug Industry Has Brought Huge Cost Savings. That May Be Changing." is from the August 01, 2017 Business section of The Washington Post. It was written by Carolyn Y. Johnson and narrated by Sam Scholl.